Employers have until March 1 to notify the Centers for Medicare and Medicaid Services whether their drug plan is creditable or noncreditable.

These women were all introduced to me by a fan of this series, Eric Silverman! Eric is a great advocate for our industry and for women in our industry, so I love the extra support he has been providing to this column by making great recommendations for some incredible...

In this fast-paced interview, we discuss different models of DPC and how the next version of DPC has been reverse engineered to include as many different lines of service as possible under a simple, affordable monthly pricing structure.

A proposed national "Right to Try" law would make it easier for terminally ill patients to get access to experimental drugs, but physicians and medical ethicists, as well as the drug industry, oppose such legislation.